M
Mario Boccadoro
Researcher at University of Turin
Publications - 670
Citations - 39049
Mario Boccadoro is an academic researcher from University of Turin. The author has contributed to research in topics: Multiple myeloma & Lenalidomide. The author has an hindex of 83, co-authored 638 publications receiving 34589 citations. Previous affiliations of Mario Boccadoro include Mount Sinai Hospital.
Papers
More filters
Journal ArticleDOI
Targeting HIF-1α Regulatory Pathways as a Strategy to Hamper Tumor-Microenvironment Interactions in CLL
Candida Vitale,Valentina Griggio,Chiara Riganti,Maria Todaro,Joanna Kopecka,Rebecca Jones,Chiara Salvetti,Elia Boccellato,Francesca Perutelli,Claudia Voena,Laura Godio,Mario Boccadoro,Marta Coscia +12 more
TL;DR: In this article, the authors demonstrate that the CXCL12/CXCR4 axis plays a pivotal role in the positive regulation of the α subunit of HIF-1 that occurs in CLL cells co-cultured with stromal cells (SC).
Journal ArticleDOI
Diagnostic and Therapeutic Challenges in the Management of Intermediate and Frail Elderly Multiple Myeloma Patients.
TL;DR: This review analyzes the available tools for the assessment of frailty and possible strategies to improve the discriminative power of the scores and expand their use in real-life and clinical trial settings and addresses the main therapeutic challenges in the management of intermediate-fit and frail MM patients at diagnosis and at relapse.
Journal ArticleDOI
MRD Evaluation By PET/CT According to Deauville Criteria Combined with Multiparameter Flow Cytometry in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients Enrolled in the Phase II Randomized Forte Trial
Elena Zamagni,Cristina Nanni,Luca Dozza,Delia Rota Scalabrini,Paola Omedè,Rossella Ribolla,Monica Galli,Manuela Racca,Renato Zambello,Barbara Gamberi,Domenico Albano,Annibale Versari,Mariella Grasso,Rossella Troia,Tonino Spadano,Francesca Patriarca,Marina Ruggeri,Marco Rensi,Anna Pascarella,Pietro Zucchetta,Paola Tacchetti,Stefano Fanti,Mario Boccadoro,Michele Cavo,Stefania Oliva +24 more
TL;DR: This analysis aimed at comparing MRD data by PET/TC assessment and MFC in the multicenter phase II randomized FORTE trial for NDTEMM patients, finding no significant correlations between PET/CT negativity after therapy and baseline prognostic factors or PET/ CT characteristics were found.
Journal ArticleDOI
Real-World (RW) Multiple Myeloma (MM) Patients (Pts) Remain Under-Represented in Clinical Trials Based on Standard Laboratory Parameters and Baseline Characteristics: Analysis of over 3,000 Pts from the Insight MM Global, Prospective, Observational Study
Vania Hungria,Hans C. Lee,Rafat Abonour,Robert M. Rifkin,Evangelos Terpos,Xavier Leleu,Caitlin Costello,Frits van Rhee,Katja Weisel,Noemi Puig,Jesus G. Berdeja,Gordon Cook,Saad Z. Usmani,Michael A. Thompson,Mario Boccadoro,Jeffrey A. Zonder,Andrew Spencer,Roman Hájek,Suzanne R. Fanning,Kevin Boyd,Jim Omel,Mira Armour,Kathryn E. Morgan,Ronak S. Patel,Gary L. Carlson,Renda H. Ferrari,Dawn Marie Stull,Kaili Ren,Dasha Cherepanov,James V. Pottala,Ajai Chari +30 more
TL;DR: RCT eligibility in INSIGHT MM is analyzed, with a focus on the treatment of frail MM pts in the real world, and finds that Frail pts are particularly likely to be ineligible for RCTs based on these standard criteria.
Journal Article
Gay F, Magarotto V, Crippa C, et al. Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: Updated results. (Blood (2013) 122, 8 (1376-1383))
Valeria Magarotto,Claudia Crippa,Norbert Pescosta,Tommasina Guglielmelli,Federica Cavallo,Sara Pezzatti,Samantha Ferrari,Anna Marina Liberati,Stefania Oliva,Francesca Patriarca,Massimo Offidani,Paola Omedè,Vittorio Montefusco,Maria Teresa Petrucci,Nicola Giuliani,Roberto Passera,Giuseppe Pietrantuono,Mario Boccadoro,Paolo Corradini,Antonio Palumbo +19 more